Previous reports showed that hCAP18/LL-37 expression is up regulated in ovarian tumors and promotes tumor progression through direct stimulation of tumor cells, initiation of angiogenesis and recruitment of immune cells [14], [18], [19]. Here, CAMP is linked to ovarian neoplasm.